Raltegravir treatment response in an HIV-2 infected patient: a case report

被引：46
作者：
Garrett, Nigel
Xu, Li [2 ]
Smit, Erasmus [2 ]
Ferns, Bridget [3 ]
El-Gadi, Saleh
Anderson, Jane [1 ]
机构：
[1] Homerton Univ Hosp NHS Fdn Trust, Ctr Study Sexual Hlth & HIV, London E9 6SR, England
[2] W Midlands Pub Hlth Lab, Hlth Protect Agcy, Birmingham, W Midlands, England
[3] UCL Royal Free & Univ Coll Med Sch, Ctr Virol, London WC1E 6BT, England
来源：
AIDS | 2008年 / 22卷 / 09期
关键词：
D O I：
10.1097/QAD.0b013e3282f9b165
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1091 / 1092
页数：2
相关论文
共 10 条
  • [1] Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial
    Grinsztejn, Beatriz
    Nguyen, Bach-Yen
    Katlama, Christine
    Gatell, Jose M.
    Lazzarin, Adriano
    Vittecoq, Daniel
    Gonzalez, Charles J.
    Chen, Joshua
    Harvey, Charlotte M.
    Isaacs, Robin D.
    [J]. LANCET, 2007, 369 (9569) : 1261 - 1269
  • [2] Hazuda DJ, 2007, ANTIVIR THER, V12, pS10
  • [3] Malet I, 2007, ANTIVIR THER, V12, pS9
  • [4] Rapid and durable Antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection - Results of a 48-week controlled study
    Markowitz, Martin
    Nguyen, Bach-Yen
    Gotuzzo, Eduardo
    Mendo, Fernando
    Ratanasuwan, Winai
    Kovacs, Colin
    Prada, Guillermo
    Morales-Ramirez, Javier O.
    Crumpacker, Clyde S.
    Isaacs, Robin D.
    Gilde, Lucinda R.
    Wan, Hong
    Miller, Michael D.
    Wenning, Larissa A.
    Teppler, Hedy
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (02) : 125 - 133
  • [5] McColl DJ, 2007, ANTIVIR THER, V12, pS11
  • [6] Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors
    Ntemgwa, Michel
    Brenner, Bluma G.
    Oliveira, Maureen
    Moisi, Daniela
    Wainberg, Mark A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) : 604 - 610
  • [7] Parkin NT, 2004, ANTIVIR THER, V9, P3
  • [8] Structure of HIV-2 reverse transcriptase at 2.35-Å resolution and the mechanism of resistance to non-nucleoside inhibitors
    Ren, J
    Bird, LE
    Chamberlain, PP
    Stewart-Jones, GB
    Stuart, DI
    Stammers, DK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) : 14410 - 14415
  • [9] ROQUEBERT B, 2007, 11 EUR AIDS C 2007
  • [10] XU L, AIDS RES HU IN PRESS
1